Novartis, slammed by Korean scandal, tweaks its ethics, compliance policies
Rocked by a corruption scandal in Korea and facing a kickbacks probe in Greece, Novartis says it's strengthening and simplifying its global ethics and compliance approach. The Swiss drug giant is aiming to shift from policing to coaching, with a compliance unit focused on helping local units make the right decisions. Novartis also wants to simplify its policies so they are easy to understand. Last month, Korean authorities handed out a $50 million fine and suspended coverage on several Novartis meds in relation to a bribery probe in the country. Novartis employees conducted a kickbacks scheme t...